2m 2m 2m 2m 2m 2m 2m
CRISPR THERAP N (CRSP)
NASDAQ
$55.35-$0.09 (-0.16%)
Price as of Oct 02, 2026 6:28 PM EDT- $5.5BMarket Cap
- -23.87%1-Year Change
- BiotechnologyIndustry
CRISPR THERAP N (CRSP)
$55.35-$0.09 (-0.16%)
Earnings Score
Valuation | CRSP | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | -1 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | CRSP | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 4.18% | ||
12-Month Momentum | -14.12% | ||
3-Month Risk Adjusted Momentum | 17.32% | ||
12-Month Risk Adjusted Momentum | -24.28% |
True Yield
Valuation | CRSP | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | -0.71% | ||
Net Debt Paydown Yield | -0.01% |
Financial Health Score
Valuation | CRSP | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 7 |